Stempoint Capital’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
Other funds holding JNJ
Stempoint Capital's JNJ Position: Q2 2026 in Review
Stempoint Capital sold out of Johnson & Johnson (JNJ) in Q2 2026, closing a stake of 15,415 shares — an estimated $3.77M sold.
Stempoint Capital first reported a position in JNJ in Q4 2023 and held it in 3 quarters. The position peaked at $9.56M in Q4 2023. 4,677 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.
- Stempoint Capital reported no remaining Johnson & Johnson position as of Q2 2026 after selling out during the quarter.
- Stempoint Capital sold 15,415 Johnson & Johnson shares in Q2 2026, an estimated $3.77M.
- Stempoint Capital first reported a position in Johnson & Johnson in Q4 2023 and held it in 3 quarters.
- Stempoint Capital's Johnson & Johnson position peaked at $9.56M in Q4 2023.
- 4,677 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.
Based on Stempoint Capital's 13F filing for Q2 2026, filed 14 Aug 2026.